"i 9 Oval" Pill Images
The following drug pill images match your search criteria.
DANTRIUM 50mg 0149 0031
Dantrolene Sodium
- Strength
- 50 mg
- Imprint
- DANTRIUM 50mg 0149 0031
- Color
- Brown & Orange
- Shape
- Capsule/Oblong
VIBRA PFIZER 094
1 / 2
Loading
ABRIKA 109 ABRIKA 109
Logo (Actavis) 2918 Logo (Actavis) 2918
Diltiazem Hydrochloride Extended-Release
- Strength
- 360 mg
- Imprint
- Logo (Actavis) 2918 Logo (Actavis) 2918
- Color
- Blue & White
- Shape
- Capsule/Oblong
WPI 2359
Topiramate Extended-Release
- Strength
- 200 mg
- Imprint
- WPI 2359
- Color
- Pink
- Shape
- Capsule/Oblong
1 / 4
Loading
DANTRIUM 50 mg 0149 0031
Dantrium
- Strength
- 50 mg
- Imprint
- DANTRIUM 50 mg 0149 0031
- Color
- Orange / Tan
- Shape
- Capsule/Oblong
299 Cipla
Duloxetine Hydrochloride Delayed-Release
- Strength
- 60 mg
- Imprint
- 299 Cipla
- Color
- Blue / Clear
- Shape
- Capsule/Oblong
Cipla 915 125 mg
1 / 2
Loading
DPI 894
Guaifenesin and pseudoephedrine
- Strength
- 250 mg / 120 mg
- Imprint
- DPI 894
- Color
- White / Clear
- Shape
- Capsule/Oblong
DANTRIUM 25mg 0149 0030
Dantrolene Sodium
- Strength
- 25 mg
- Imprint
- DANTRIUM 25mg 0149 0030
- Color
- Brown & Orange
- Shape
- Capsule/Oblong
1 / 2
Loading
93 93 COTRIM DS
TISH 8962
Logo (Actavis) 0495 Logo (Actavis) 0495
Budesonide (Enteric Coated)
- Strength
- 3 mg
- Imprint
- Logo (Actavis) 0495 Logo (Actavis) 0495
- Color
- Pink & White
- Shape
- Capsule/Oblong
APRESAZIDE 25/25 CIBA 139
Apresazide
- Strength
- 25 mg / 25 mg
- Imprint
- APRESAZIDE 25/25 CIBA 139
- Color
- Blue / White
- Shape
- Capsule/Oblong
1 / 2
Loading
ICN 0901 ICN 0901
1 / 2
Loading
Logo Zenith 30mg 4289
Nicardipine Hydrochloride
- Strength
- 30 mg
- Imprint
- Logo Zenith 30mg 4289
- Color
- Blue
- Shape
- Capsule/Oblong
1 / 2
Loading
Logo (Actavis) 3091 Logo (Actavis) 3091
Morphine Sulfate Extended-Release
- Strength
- 60 mg
- Imprint
- Logo (Actavis) 3091 Logo (Actavis) 3091
- Color
- Green
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.